Red Light Holland Announces Filament Health Shareholder Approval of Acquisition

Toronto, Ontario--(Newsfile Corp. - April 27, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light") and Filament Health Corp. (OTC: FLHLF) ("Filament") are pleased to announce that, further to their joint press release dated March 10, 2026 and March 23, 2026, Filament's shareholders (the "Filament Shareholders") have approved each of the matters voted on at the Filament annual general and special meeting ("Filament Meeting") held on April 24, 2026, including approving the proposed plan of arrangement under the Business Corporations Act (British Columbia) (the "Arrangement") with Red Light, which will result in the acquisition of all the issued and outstanding common shares of Filament ("Filament Shares") by Red Light. As disclosed in Filament's management information circular dated April 2, 2026 (the "Filament Circular"), the special resolution approving the Arrangement (the "Arrangement Resolution") required the approval of: (i) 66⅔% of the votes cast by Filament Shareholders present in person or represented by proxy at the Filament Meeting; and (iii) a simple majority of votes cast by Filament Shareholders present in person or represented by proxy at the Filament Meeting after excluding votes cast by Filament Shareholders who are required to be excluded to obtain "minority approval" in accordance with Section 8.1 of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101").